Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in ...

Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...

A panel of federal health experts on Wednesday recommended expanded vaccine options for several diseases, including ...

A study presented at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute ...

With the arrival of spring the most severe phase of the 2024-25 respiratory illness has officially come to an end, according to the Grant County Health District. "Since March 2025, emergency ...

A federal panel of medical experts on Wednesday recommended an expansion of respiratory syncytial virus (RSV) vaccinations ...

A federal panel of experts on Wednesday recommended an expansion of RSV vaccinations for adults and a new combination shot as ...

A study reveals that Respiratory Syncytial Virus-associated Acute Respiratory Infection increases death risk in adults. The ...

Major study shows that adults with respiratory syncytial virus-associated acute respiratory infection face a 2.7-fold higher ...

A year after narrowing its recommendation for who should use vaccines to defend against respiratory syncytial virus (RSV), a ...

The committee endorsed lowering the age at which some people can receive RSV vaccines, but stopped short of recommending ...